Clinical trials: Polysubstance Addiction
Opioid Use Disorder, Polysubstance Addiction
The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy
The opioid crisis continues its devastating impact on Canada, with over 13,900 deaths recorded between 2016 and 2019. Dangerous prescription opioid usage persists, affecting 12.3% of Canadians in 2018.
- Conditions
- Opioid Use Disorder, Polysubstance Addiction, Substance Use
- Trial name
- NCT06211972
- Testing
- OpiVenture
- Volunteers
- 96 people
- Sponsor
- Dalhousie University
Depression, Anxiety
Microcurrent Neurofeedback as an Adjunct to Standard Care for Substance Use Disorders
The goal of this clinical trial is to learn whether adding Microcurrent Neurofeedback (MCN) to standard residential treatment helps adults with substance use disorder more than standard treatment alone.
- Conditions
- Depression, Anxiety, Substance Use Disorder (SUD), Post Traumatic Stress Disorder
- Trial name
- NCT07737652
- Testing
- Microcurrent Neurofeedback (MCN), Standard Care for Substance Use Disorder
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- University of Alabama, Tuscaloosa
Drug Addiction, Polysubstance Addiction
Mapping And Preventing Relapse Risk in Polydrug Users
This Interventional two-arm comparative study will evaluate whether a mindfulness-based strategy (MBS) improves outcomes for adults with substance use disorders (polydrug users) compared with treatment-as-usual (TAU).
- Trial name
- NCT07161986
- Testing
- Mindfullness based Sobriety (MBS)
- Where
- Pakistan
- Volunteers
- 130 people
- Sponsor
- Institute of Psychology, Chinese Academy of Sciences
Polysubstance Addiction, Opioid Medication Assisted Treatment
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among…
- Conditions
- Polysubstance Addiction, Opioid Medication Assisted Treatment, Treatment Adherence, Retention in Care
- Trial name
- PRISM (NCT05973838)
- Testing
- Peer-Delivered Behavioral Activation ("Peer Activate")
- Where
- 4 sites in United States
- Volunteers
- 160 people
- Sponsor
- University of Maryland, College Park